Behind the markets
Behind the markets

Daily Trades

TRADE ALERT: Sell half of Krystal Bio for a 120% gain (KRYS)

I recommend selling half your shares in Krystal Biotech (SYM: KRYS) here at $170.09, a 120% gain from our recommended price of $76.94. 
Learn More

TRADE ALERT: Krystal Bio Jumps 40% on Strong Earnings

Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS). 
Learn More

July 2023 Issue: Amicus Therapeutics Inc. (SYM: FOLD)

Learn More

TRADE ALERT: Lock in some profits on Krystal Biotech (SYM: KRYS)

Trade Alert: Lock in some profits on Krystal Biotech (SYM: KRYS)....
Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

UPDATE: Krystal Biotech & Schrodinger Up Big Today – what to do

Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time. 
Learn More

UPDATE: Krystal Bio hits all-time high on FDA approval

Krystal Biotech (SYM: KRYS) hit an all-time high today of $95 on winning FDA approval of Vyjuvek, a topical gene therapy for dystrophic epidermolysis bullosa (DEB).
Learn More

August 2022 Issue: Krystal Biotech (NAS:KRYS)

Investors may want to keep an eye on the biotech boom. For one, the sector is still one of the safest, most recession-proof investments around.
Learn More

October 8, 2019 – Portfolio Update

Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

777 subscribers

Behind the Markets: independent research for independent investors.

Behind the Markets
In this video, we dive deep into the current geopolitical tensions involving the United States, Israel, and Iran. Our video dissects the possible repercussions of an escalated conflict in the Middle East and why it might be a catastrophic mistake for the U.S. to engage in a war that doesn't align with national security priorities. We explore the historical context of the shadow war between Israel and Iran, and the implications of Israel's recent actions that indirectly involved Iranian territory. This includes the strike on an Iranian consulate, a move that escalated tensions but was met with a measured response from Iran, indicating a possible avoidance of further escalation. Additionally, the video sheds light on the broader implications for U.S. foreign policy, emphasizing the importance of focusing on domestic priorities and strategic international investments, like supporting Ukraine and monitoring developments in Taiwan due to its significance in semiconductor production. Join us as we unravel the complexities of these interactions, the potential mistakes in escalating conflicts, and the strategic choices the U.S. might consider to maintain global stability while securing its interests. Your thoughts and opinions are invaluable—share them in the comments below and let's discuss what the future should hold for U.S. involvement in Middle East affairs. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxROHJOTHBIX2t3

Israel vs. Iran: The Mistake That Could Drag the U.S. into War

In today’s video, we delve deep into the often overlooked geopolitical risks associated with our global dependency on artificial intelligence (AI) technologies. While AI continues to shape the future in extraordinary ways, there's a critical factor that might disrupt this progress: the semiconductor supply chain. Most of the world's advanced semiconductors, crucial for everything from mobile phones to AI systems, are manufactured in Taiwan by Taiwan Semiconductor Manufacturing Company (TSMC). However, with rising tensions in the region and China's increasing assertiveness towards Taiwan, the stability of this supply chain is under significant threat. In the past month alone, major companies like Samsung, TSMC, and Intel have received substantial funding from the U.S. government, aimed at boosting semiconductor production within the United States. This strategic move highlights a growing awareness of the risks posed by potential conflicts in Taiwan—a scenario that could have profound impacts on global technology supply chains. Join us as we analyze these complex dynamics, including the strategic moves by global and national powers to secure semiconductor production, and discuss the potential implications on AI development and broader technological advancements. We'll also offer insights into the actions companies and governments are taking to mitigate these risks. Don't forget to like, subscribe, and click the bell icon to stay updated on our latest content, where we continue to uncover the critical intersections between technology and geopolitics. Share your thoughts in the comments below: How do you think these developments will affect the future of technology and global stability? ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxzZ0ZxaUhtYVpJ

The Looming Threat to Nvidia and AI

In today’s video, we’re diving deep into a topic that hits close to home for many of us. The Department of Justice (DOJ) is taking a monumental step by launching an antitrust lawsuit against a company that’s not just a tech giant but a staple in our daily lives - Apple. From the moment we wake up, many of us are glued to our iPhones. It's our portal to the world, our little escape, and frankly, a big part of our personal spaces. But what happens when the trusty device in your pocket becomes the center of a massive antitrust case? This is not just any case; it's possibly the first time in history the DOJ is targeting a company we have a deeply personal relationship with. 📲 We Want to Hear from You! 💬 This situation is complex, and opinions are bound to vary. Do you see Apple’s actions as monopolistic, or are they simply capitalizing on a successful business model they built from the ground up? Is this lawsuit a step towards protecting consumers, or could it stifle innovation? Drop your thoughts, experiences, and opinions in the comments below. Let’s have a meaningful discussion on what this means for the future of technology, consumer rights, and how we interact with the digital world. 🔔 Stay Informed 🔔 If you’re passionate about technology or just love to stay on top of major news stories that affect your daily life, make sure to hit that subscribe button and turn on notifications. We bring you insightful analysis, break down complex issues, and share stories that matter to you. Thank you for watching, have a great day, and see you in the comments! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3Lk93WXpqalBhVE1F

The Empire Strikes Back: DOJ's Latest Move Against Apple

Load More... Subscribe

Recent posts

The Top Benefits of Investing in an Exchange Traded Funds

Chart of Day: Canopy Growth (CGC) – 4/18

The Top Benefits of Investing in an Exchange Traded Fund – 4/18

Chart of Day: Salesforce (CRM) – 4/17

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

TRADE ALERT: Sell half of Krystal Bio for a 120% gain (KRYS)

I recommend selling half your shares in Krystal Biotech (SYM: KRYS) here at $170.09, a 120% gain from our recommended price of $76.94. 
Learn More

TRADE ALERT: Krystal Bio Jumps 40% on Strong Earnings

Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS). 
Learn More

July 2023 Issue: Amicus Therapeutics Inc. (SYM: FOLD)

Learn More

TRADE ALERT: Lock in some profits on Krystal Biotech (SYM: KRYS)

Trade Alert: Lock in some profits on Krystal Biotech (SYM: KRYS)....
Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

UPDATE: Krystal Biotech & Schrodinger Up Big Today – what to do

Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time. 
Learn More

UPDATE: Krystal Bio hits all-time high on FDA approval

Krystal Biotech (SYM: KRYS) hit an all-time high today of $95 on winning FDA approval of Vyjuvek, a topical gene therapy for dystrophic epidermolysis bullosa (DEB).
Learn More

August 2022 Issue: Krystal Biotech (NAS:KRYS)

Investors may want to keep an eye on the biotech boom. For one, the sector is still one of the safest, most recession-proof investments around.
Learn More

October 8, 2019 – Portfolio Update

Learn More

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2024 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.